153 related articles for article (PubMed ID: 15848671)
1. Tacrolimus for primary liver transplantation: 12 to 15 years actual follow-up with safety profile.
Jain A; Marcos A; Reyes J; Mazariagos G; Kashyap R; Eghtesad B; Marsh W; Fontas P; De Vera M; Costa G; Patel K; Gadomski M; Starzl T; Fung J
Transplant Proc; 2005 Mar; 37(2):1207-10. PubMed ID: 15848671
[TBL] [Abstract][Full Text] [Related]
2. The absence of chronic rejection in pediatric primary liver transplant patients who are maintained on tacrolimus-based immunosuppression: a long-term analysis.
Jain A; Mazariegos G; Pokharna R; Parizhskaya M; Kashyap R; Kosmach-Park B; Smith A; Fung JJ; Reyes J
Transplantation; 2003 Apr; 75(7):1020-5. PubMed ID: 12698091
[TBL] [Abstract][Full Text] [Related]
3. Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients.
Jacob DA; Neumann UP; Bahra M; Klupp J; Puhl G; Neuhaus R; Langrehr JM
Clin Transplant; 2006; 20(2):211-20. PubMed ID: 16640529
[TBL] [Abstract][Full Text] [Related]
4. Liver transplantation for primary biliary cirrhosis: influence of primary immunosuppression on survival.
Jacob DA; Neumann UP; Bahra M; Langrehr JM; Neuhaus P
Transplant Proc; 2005 May; 37(4):1691-2. PubMed ID: 15919432
[TBL] [Abstract][Full Text] [Related]
5. Primary immunosuppression with tacrolimus after liver transplantation: 12-years follow-up.
Jonas S; Neuhaus R; Junge G; Klupp J; Theruvat T; Langrehr JM; Settmacher U; Neuhaus P
Int Immunopharmacol; 2005 Jan; 5(1):125-8. PubMed ID: 15589470
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of liver transplants for chronic hepatitis C: a 10-year follow-up.
Neumann UP; Berg T; Bahra M; Puhl G; Guckelberger O; Langrehr JM; Neuhaus P
Transplantation; 2004 Jan; 77(2):226-31. PubMed ID: 14742986
[TBL] [Abstract][Full Text] [Related]
7. Safety of minimal immunosuppression in liver transplantation for hepatoblastoma.
Suh MY; Wang K; Gutweiler JR; Misra MV; Krawczuk LE; Jenkins RL; Lillehei CW; Jonas MM; Kim HB
J Pediatr Surg; 2008 Jun; 43(6):1148-52. PubMed ID: 18558198
[TBL] [Abstract][Full Text] [Related]
8. Long-term evaluation of cyclosporine and tacrolimus based immunosuppression in pediatric liver transplantation.
Hasenbein W; Albani J; Englert C; Spehr A; Grabhorn E; Kemper MJ; Burdelski M; Ganschow R
Pediatr Transplant; 2006 Dec; 10(8):938-42. PubMed ID: 17096762
[TBL] [Abstract][Full Text] [Related]
9. Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: an association with C2 monitoring and recipient age.
Tjon AS; Sint Nicolaas J; Kwekkeboom J; de Man RA; Kazemier G; Tilanus HW; Hansen BE; van der Laan LJ; Tha-In T; Metselaar HJ
Liver Transpl; 2010 Jul; 16(7):837-46. PubMed ID: 20583092
[TBL] [Abstract][Full Text] [Related]
10. Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.
Testillano M; Fernandez JR; Suarez MJ; Gastaca M; Bustamante J; Pijoan JI; Montejo M; Valdivieso A; Ruiz P; Gonzalez J; Ortiz de Urbina J
Transplant Proc; 2009 Apr; 41(3):1041-3. PubMed ID: 19376421
[TBL] [Abstract][Full Text] [Related]
11. Comparative long-term evaluation of tacrolimus and cyclosporine in pediatric liver transplantation.
Jain A; Mazariegos G; Kashyap R; Green M; Gronsky C; Starzl TE; Fung J; Reyes J
Transplantation; 2000 Aug; 70(4):617-25. PubMed ID: 10972220
[TBL] [Abstract][Full Text] [Related]
12. One thousand consecutive primary liver transplants under tacrolimus immunosuppression: a 17- to 20-year longitudinal follow-up.
Jain A; Singhal A; Fontes P; Mazariegos G; DeVera ME; Cacciarelli T; Lopez RC; Sindhi R; Humar A; Marsh JW
Transplantation; 2011 May; 91(9):1025-30. PubMed ID: 21378604
[TBL] [Abstract][Full Text] [Related]
13. [Liver transplantation for primary biliary cirrhosis: retrospective analysis of results at a single center].
Jacob DA; Neumann UP; Bahra M; Langrehr JM; Neuhaus P
Dtsch Med Wochenschr; 2006 Oct; 131(42):2327-32. PubMed ID: 17043982
[TBL] [Abstract][Full Text] [Related]
14. Corticosteroid-free immunosuppression in pediatric liver transplantation: safety and efficacy after a short-term follow-up.
Cintorino D; Riva S; Spada M; Minervini M; Sonzogni A; Foglieni CS; Gruttadauria S; Verzaro R; Henderson K; Aricò M; Gridelli B
Transplant Proc; 2006 May; 38(4):1099-100. PubMed ID: 16757276
[TBL] [Abstract][Full Text] [Related]
15. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
Levy G; Grazi GL; Sanjuan F; Wu Y; Mühlbacher F; Samuel D; Friman S; Jones R; Cantisani G; Villamil F; Cillo U; Clavien PA; Klintmalm G; Otto G; Pollard S; McCormick PA
Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
[TBL] [Abstract][Full Text] [Related]
16. Indications and management of everolimus after liver transplantation.
Bilbao I; Sapisochin G; Dopazo C; Lazaro JL; Pou L; Castells L; Caralt M; Blanco L; Gantxegi A; Margarit C; Charco R
Transplant Proc; 2009; 41(6):2172-6. PubMed ID: 19715864
[TBL] [Abstract][Full Text] [Related]
17. A prospective randomized trial comparing tacrolimus and steroids with tacrolimus monotherapy in liver transplantation: the impact on recurrence of hepatitis C.
Margarit C; Bilbao I; Castells L; Lopez I; Pou L; Allende E; Escartin A
Transpl Int; 2005 Dec; 18(12):1336-45. PubMed ID: 16297052
[TBL] [Abstract][Full Text] [Related]
18. Thrombotic and nonthrombotic hepatic artery complications in adults and children following primary liver transplantation with long-term follow-up in 1000 consecutive patients.
Jain A; Costa G; Marsh W; Fontes P; Devera M; Mazariegos G; Reyes J; Patel K; Mohanka R; Gadomski M; Fung J; Marcos A
Transpl Int; 2006 Jan; 19(1):27-37. PubMed ID: 16359374
[TBL] [Abstract][Full Text] [Related]
19. Effect of long-term tacrolimus immunosuppression on renal function in liver transplant recipients.
Corman SL; Coley KC; Schonder KS
Pharmacotherapy; 2006 Oct; 26(10):1433-7. PubMed ID: 16999653
[TBL] [Abstract][Full Text] [Related]
20. Repeated steroid pulse therapies in HCV-positive liver recipients: significant risk factor for HCV-related graft loss.
Bahra M; Neumann UP; Jacob D; Langrehr JM; Neuhaus P
Transplant Proc; 2005 May; 37(4):1700-2. PubMed ID: 15919436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
